H3B-6545

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameH3B-6545
Drug Alias NameH3B-6545
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha antagonists
TargetsEstrogen receptor alpha
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomFrance +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesH3 Biomedicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesEisai IncEisai Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A